Talaporfin Sodium
他拉泊芬钠
Report date: 2022/07/27 14:32:54
NME
Base Information
Drug NameTalaporfin Sodium
Drug Alias Name +[8]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[20]
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2003/10/16
Country/Territory +[18]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesMeiji Seika Pharma
China Registration ClassN/A
Develop Information
Active CompaniesMeiji Seika PharmaLight Sciences Oncology Inc
Inactive CompaniesUniversity of California IrvineLight Sciences Llc
Active Indications
Inactive Indications +[18]